After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Relay Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Relay Therapeutics Inc is $1.13B. A total of 2.43 million shares were traded on the day, compared to an average of 1.78M shares.
In the most recent transaction, Patel Sanjiv sold 62,073 shares of RLAY for 7.00 per share on Nov 03 ’25. After the transaction, the President and CEO now owns 703,215 company shares. In a previous transaction on Oct 29 ’25, Rahmer Peter sold 21,394 shares at 7.50 per share. RLAY shares that the insider owns now total 337,469.
Among the insiders who sold shares, Rahmer Peter disposed of 19,135 shares on Oct 28 ’25 at a per-share price of $7.29. This resulted in the insider holding 358,863 shares of RLAY after the transaction. In another insider transaction, Catinazzo Thomas sold 21,664 shares at $7.29 per share on Oct 28 ’25. Company shares held by the Chief Financial Officer now total 313,631.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, RLAY has a high of $7.64 and a low of $1.77.
As of this writing, RLAY has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.53. The company reported an EPS of -$0.45 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $3.52, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.54.
